glp 1 agonists examples Is GLP-1 Safe for Weight Loss? Peptides, Benefits & Risks Mapping the effectiveness and risks

Learn key patient education tips for GLP-1 care management, the importance of multidisciplinary care teams and how remote care providers fit into the equation.

Clinical Significance: The 2025 updates reaffirm that while HbA1c remains central, a one-number-fits-all strategy is outdated

Get started with Nooms Microdose GLP-1Rx Program.

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis

Aims/hypothesis Tirzepatide is a novel dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) currently under review for marketing approval